Upgrade to SI Premium - Free Trial

Bristol-Myers Squibb Co. (BMY) PT Raised to $60 at BMO Capital

May 1, 2026 4:10 AM
BMO Capital analyst Evan David Seigerman raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change